Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Total Current Liabilities (2022 - 2025)

Historic Total Current Liabilities for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to $3.1 million.

  • Neuraxis' Total Current Liabilities rose 1813.19% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 1813.19%. This contributed to the annual value of $2.4 million for FY2024, which is 2904.31% up from last year.
  • Neuraxis' Total Current Liabilities amounted to $3.1 million in Q3 2025, which was up 1813.19% from $2.3 million recorded in Q2 2025.
  • Neuraxis' 5-year Total Current Liabilities high stood at $11.4 million for Q2 2023, and its period low was $1.9 million during Q4 2023.
  • For the 4-year period, Neuraxis' Total Current Liabilities averaged around $4.2 million, with its median value being $2.7 million (2024).
  • As far as peak fluctuations go, Neuraxis' Total Current Liabilities tumbled by 7297.72% in 2023, and later skyrocketed by 2904.31% in 2024.
  • Quarter analysis of 4 years shows Neuraxis' Total Current Liabilities stood at $7.0 million in 2022, then plummeted by 72.98% to $1.9 million in 2023, then grew by 29.04% to $2.4 million in 2024, then grew by 29.34% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $2.3 million for Q2 2025, and $2.1 million during Q1 2025.